Dina Kao

7.2k total citations · 5 hit papers
86 papers, 3.8k citations indexed

About

Dina Kao is a scholar working on Infectious Diseases, Molecular Biology and Epidemiology. According to data from OpenAlex, Dina Kao has authored 86 papers receiving a total of 3.8k indexed citations (citations by other indexed papers that have themselves been cited), including 62 papers in Infectious Diseases, 44 papers in Molecular Biology and 27 papers in Epidemiology. Recurrent topics in Dina Kao's work include Clostridium difficile and Clostridium perfringens research (62 papers), Gut microbiota and health (43 papers) and Gastrointestinal motility and disorders (26 papers). Dina Kao is often cited by papers focused on Clostridium difficile and Clostridium perfringens research (62 papers), Gut microbiota and health (43 papers) and Gastrointestinal motility and disorders (26 papers). Dina Kao collaborates with scholars based in Canada, United States and United Kingdom. Dina Kao's co-authors include Karen Madsen, Naomi Hotte, Gane Ka‐Shu Wong, Jordan Patterson, Andrew L. Mason, Huiping Xu, Brandi Roach, Juan Jovel, Sandra O’Keefe and Weiwei Wang and has published in prestigious journals such as JAMA, Nature Medicine and Nature Communications.

In The Last Decade

Dina Kao

81 papers receiving 3.8k citations

Hit Papers

Characterization of the Gut Microbiome Using 16S or Shotg... 2016 2026 2019 2022 2016 2017 2021 2024 2024 200 400 600
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Characterization of the Gut Microbiome Using 16S or Shotgun Metagenomics
    2016 607 citations Jordan Patterson, Naomi Hotte et al. Frontiers in Microbiology profile →
  2. Effect of Oral Capsule– vs Colonoscopy-Delivered Fecal Microbiota Transplantation on Recurrent Clostridium difficile Infection
    2017 438 citations Dina Kao, Brandi Roach et al. profile →
  3. Fecal microbial transplantation and fiber supplementation in patients with severe obesity and metabolic syndrome: a randomized double-blind, placebo-controlled phase 2 trial
    2021 206 citations Valentin Mocanu, Zhengxiao Zhang et al. Nature Medicine profile →
  4. Fecal microbiota transplantation: current challenges and future landscapes
    2024 134 citations Abbas Yadegar, Haggai Bar‐Yoseph et al. Clinical Microbiology Reviews profile →
  5. AGA Clinical Practice Guideline on Fecal Microbiota–Based Therapies for Select Gastrointestinal Diseases
    2024 89 citations Colleen Kelly, Dina Kao et al. Gastroenterology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Dina Kao Canada 32 2.2k 2.1k 1.2k 869 829 86 3.8k
Susana Fuentes Netherlands 10 2.4k 1.1× 2.8k 1.4× 1.4k 1.2× 1.1k 1.3× 630 0.8× 16 4.1k
Christoph Högenauer Austria 34 1.6k 0.7× 1.2k 0.6× 807 0.7× 623 0.7× 779 0.9× 115 3.7k
Mark Smith United States 25 1.9k 0.9× 1.4k 0.7× 1.0k 0.9× 569 0.7× 651 0.8× 70 3.6k
Elaine O. Petrof Canada 33 2.8k 1.3× 1.8k 0.9× 944 0.8× 727 0.8× 649 0.8× 62 4.9k
Anne Vrieze Netherlands 2 1.6k 0.7× 2.0k 0.9× 1.0k 0.9× 725 0.8× 443 0.5× 2 2.7k
Mohammed Nabil Quraishi United Kingdom 19 2.0k 0.9× 1.1k 0.5× 676 0.6× 534 0.6× 504 0.6× 63 3.3k
Colleen Kelly United States 30 2.8k 1.3× 4.1k 2.0× 2.4k 2.1× 1.9k 2.1× 1.2k 1.4× 112 5.8k
Alexa R. Weingarden United States 14 1.7k 0.8× 1.5k 0.7× 757 0.6× 685 0.8× 408 0.5× 26 2.6k
Charlie G. Buffie United States 8 2.5k 1.2× 1.8k 0.9× 561 0.5× 431 0.5× 385 0.5× 11 3.9k
Christine H. Lee Canada 16 1.8k 0.8× 2.2k 1.1× 1.2k 1.0× 954 1.1× 499 0.6× 34 3.1k

Countries citing papers authored by Dina Kao

Since Specialization
Citations

This map shows the geographic impact of Dina Kao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dina Kao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dina Kao more than expected).

Fields of papers citing papers by Dina Kao

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dina Kao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dina Kao. The network helps show where Dina Kao may publish in the future.

Co-authorship network of co-authors of Dina Kao

This figure shows the co-authorship network connecting the top 25 collaborators of Dina Kao. A scholar is included among the top collaborators of Dina Kao based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dina Kao. Dina Kao is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wong, J. S. W., Matthew A. Croxen, Aducio Thiesen, et al.. (2025). The assembly of a hybrid type IV secretion system by a Crohn’s disease-associated Escherichia coli strain. Nature Communications. 16(1). 8797–8797.
2.
Satokari, Reetta, et al.. (2025). Prolonged effect of antibiotic therapy on the gut microbiota composition, functionality, and antibiotic resistance genes’ profiles in healthy stool donors. Frontiers in Microbiology. 16. 1589704–1589704. 1 indexed citations
3.
Yadegar, Abbas, Haggai Bar‐Yoseph, Tanya Monaghan, et al.. (2024). Fecal microbiota transplantation: current challenges and future landscapes. Clinical Microbiology Reviews. 37(2). e0006022–e0006022. 134 indexed citations breakdown →
4.
5.
Kao, Dina, Karen Wong, Humberto Jijon, et al.. (2024). Preliminary Results From a Multicenter, Randomized Trial Using Fecal Microbiota Transplantation to Induce Remission in Patients With Mild-to-Moderate Crohn's Disease. The American Journal of Gastroenterology. 120(6). 1334–1344. 6 indexed citations
6.
Churchward, Matthew A., Benjamin H. Mullish, Jesús Miguéns Blanco, et al.. (2023). Short-chain fatty and carboxylic acid changes associated with fecal microbiota transplant communally influence microglial inflammation. Heliyon. 9(6). e16908–e16908. 9 indexed citations
7.
8.
Ianiro, Gianluca, Rupert W. Leong, Tariq Iqbal, et al.. (2022). Faecal microbiota transplantation for recurrent C. difficile infections: challenges and improvement opportunities for clinical practice and healthcare systems. Alimentary Pharmacology & Therapeutics. 57(5). 549–564. 6 indexed citations
9.
Mocanu, Valentin, Zhengxiao Zhang, Edward C. Deehan, et al.. (2021). Fecal microbial transplantation and fiber supplementation in patients with severe obesity and metabolic syndrome: a randomized double-blind, placebo-controlled phase 2 trial. Nature Medicine. 27(7). 1272–1279. 206 indexed citations breakdown →
10.
Martínez-Gili, Laura, Julie A. K. McDonald, Zhigang Liu, et al.. (2020). Understanding the mechanisms of efficacy of fecal microbiota transplant in treating recurrent Clostridioides difficile infection and beyond: the contribution of gut microbial-derived metabolites. Gut Microbes. 12(1). 1810531–1810531. 34 indexed citations
11.
Huus, Kelsey E., Marcin Frankowski, Maja Pučić‐Baković, et al.. (2020). Changes in IgA-targeted microbiota following fecal transplantation for recurrent Clostridioides difficile infection. Gut Microbes. 13(1). 1–12. 13 indexed citations
12.
Mullish, Benjamin H., Julie A. K. McDonald, Jessica R. Allegretti, et al.. (2019). Microbial bile salt hydrolases mediate the efficacy of faecal microbiota transplant in the treatment of recurrent Clostridioides difficile infection. Gut. 68(10). 1791–1800. 192 indexed citations
13.
Monaghan, Tanya, Benjamin H. Mullish, Jordan Patterson, et al.. (2018). Effective fecal microbiota transplantation for recurrent Clostridioides difficile infection in humans is associated with increased signalling in the bile acid-farnesoid X receptor-fibroblast growth factor pathway. Nottingham ePrints (University of Nottingham). 8 indexed citations
14.
McDonald, Julie A. K., Benjamin H. Mullish, Alexandros Pechlivanis, et al.. (2018). Inhibiting Growth of Clostridioides difficile by Restoring Valerate, Produced by the Intestinal Microbiota. Gastroenterology. 155(5). 1495–1507.e15. 139 indexed citations
15.
Teshima, Christopher, Karen J. Goodman, Samina A. Turk, et al.. (2017). Increased Intestinal Permeability in Relatives of Patients With Crohn’s Disease Is Not Associated With Small Bowel Ulcerations. Clinical Gastroenterology and Hepatology. 15(9). 1413–1418.e1. 26 indexed citations
16.
Allegretti, Jessica R., et al.. (2017). Early Antibiotic Use After Fecal Microbiota Transplantation Increases Risk of Treatment Failure. Clinical Infectious Diseases. 66(1). 134–135. 38 indexed citations
17.
Fischer, Monika, Dina Kao, Colleen Kelly, et al.. (2016). Fecal Microbiota Transplantation is Safe and Efficacious for Recurrent or Refractory Clostridium difficile Infection in Patients with Inflammatory Bowel Disease. Inflammatory Bowel Diseases. 22(10). 2402–2409. 134 indexed citations
18.
Kao, Dina, Brandi Roach, Heekuk Park, et al.. (2015). Fecal microbiota transplantation in the management of hepatic encephalopathy. Hepatology. 63(1). 339–340. 102 indexed citations
19.
Tandon, Puneeta, Juan G. Abraldeṣ, Adam Keough, et al.. (2014). Risk of Bacterial Infection in Patients With Cirrhosis and Acute Variceal Hemorrhage, Based on Child–Pugh Class, and Effects of Antibiotics. Clinical Gastroenterology and Hepatology. 13(6). 1189–1196.e2. 76 indexed citations
20.
Kao, Dina, Stephanie J. Mah, Brian Claggett, et al.. (2013). Breaks in the wall: increased gaps in the intestinal epithelium of irritable bowel syndrome patients identified by confocal laser endomicroscopy (with videos). Gastrointestinal Endoscopy. 77(4). 624–630. 43 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Susana Fuentes Breakdown of academic impact, for papers by Christoph Högenauer Breakdown of academic impact, for papers by Mark Smith Breakdown of academic impact, for papers by Elaine O. Petrof Breakdown of academic impact, for papers by Anne Vrieze Breakdown of academic impact, for papers by Mohammed Nabil Quraishi Breakdown of academic impact, for papers by Colleen Kelly Breakdown of academic impact, for papers by Alexa R. Weingarden Breakdown of academic impact, for papers by Charlie G. Buffie Breakdown of academic impact, for papers by Christine H. Lee
Rankless by CCL
2026